Aerodynamic Measurements in the Pediatric Population
5 other identifiers
interventional
365
1 country
2
Brief Summary
The goal of this clinical trial is to create a vocal health database of people aged 4-65 with no diagnosed voice pathology. The main question it aims to answer is:
- what is the best way to assess pediatric voices; and,
- what are the differences between healthy and dysphonic pediatric voices? Participants will complete one 60 minute session involving one of three types of aerodynamic interruption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2025
CompletedFirst Posted
Study publicly available on registry
May 16, 2025
CompletedStudy Start
First participant enrolled
December 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
April 16, 2026
May 1, 2025
4.9 years
May 8, 2025
April 13, 2026
Conditions
Outcome Measures
Primary Outcomes (8)
Compare subglottic pressure across different airflow interruption methods
Subglottic pressure is measured in kPa of leakage of air between the vocal folds and the resistance to that flow during speech
60 minutes
Compare phonation threshold pressure (PTP) across airflow interruption methods
PTP is is calculated by subtracting the intraoral pressure at phonation cessation from the subglottal pressure (Ps).
60 minutes
Compare laryngeal resistance across airflow interruption methods
Pressure and airflow measurements can be taken and entered into equations (Ps = (LR) U1+ Z1U1 and Ps = (LR)U2+Z2U2) to calculate Laryngeal resistance and Ps.
90 minutes
Compare subglottic pressure between benign vocal fold lesions and normal voices
Subglottic pressure is measured in kPa of leakage of air between the vocal folds and the resistance to that flow during speech
90 minutes
Compare PTP between benign vocal fold lesions and normal voices
PTP is is calculated by subtracting the intraoral pressure at phonation cessation from the subglottal pressure (Ps).
90 minutes
Compare laryngeal resistance between benign vocal fold lesions and normal voices
Pressure and airflow measurements can be taken and entered into equations (Ps = (LR) U1+ Z1U1 and Ps = (LR)U2+Z2U2) to calculate Laryngeal resistance and Ps.
90 minutes
Compare vocal efficiency between benign vocal fold lesions and normal voices
Vocal efficiency is calculated using aerodynamic to acoustic power.
90 minutes
Compare mean airflow rate between benign vocal fold lesions and normal voices
Mean airflow (I) = Ps / laryngeal resistance (Lr).
90 minutes
Study Arms (3)
Complete airflow interruption
EXPERIMENTALIncomplete airflow interruption
EXPERIMENTALAirflow redirection
EXPERIMENTALInterventions
Participants will produce a sustained vowel into a mouthpiece (with nose-clip) connected to a PVC tube, with a balloon valve
Incomplete airflow interruption uses a Y-shaped device. The participant produces a sustained /a/ into a mouthpiece and air filter connected to the tube. The tube splits into two tubes distally.
Participant phonates through a mouthpiece into a PVC tube that splits into two paths. One path is connected to an open balloon valve. When the balloon is inflated and blocks the path, air is redirected into the other path which is gated by a one-way valve.
Eligibility Criteria
You may qualify if:
- Age 4-65 years
- Normal voice
- No history of voice or other pertinent health disorders
You may not qualify if:
- Neuromuscular disorder affecting the larynx
- History of respiratory or laryngeal disease
- History of smoking
- Hearing impairment
- Cognitive impairment that might impact ability to perform the tasks required by the study
- Age 4-17
- Laryngeal pathology
- No laryngeal disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Iowa
Iowa City, Iowa, 52242, United States
University of Wisconsin - Madison
Madison, Wisconsin, 53705, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jack Jiang, MD
University of Wisconsin, Madison
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2025
First Posted
May 16, 2025
Study Start
December 22, 2025
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
April 16, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share